Ok, so now onto pharmacotherapy - now updated to reflect the 2022 Guidelines!

Last time we talked about signs and symptoms and discussed the Frank-Starling curve. We are going to talk about the agents used in HF and how they affect this curve.

Clinical, Residency, PracticeBrandon DysonNovember 5, 2024heart failure, systolic heart failure, diastolic heart failure, HFpEF, HFrEF, HF, CHF, Clinical Pearls, congestive heart failure, cardiovascular, digoxin

Heart Failure Part 2: Signs and Symptoms

In our last post, we talked about the hemodynamics of HF. We talked about Right and Left HF as well as Systolic and Diastolic HF (now called HFrEF and HFpEF, respectively). Now let’s talk about the Signs and Symptoms of Heart Failure (HF).

Clinical, Residency, PracticeCourtney HowellAugust 12, 2024heart failure, systolic heart failure, diastolic heart failure, congestive heart failure, cardiovascular, pathophysiology, Clinical Pearls, PCWP, CKD, Guest Post, CHF, HF, HFpEF, HFrEF

The ABCs of LVADs for Pharmacists

Heart failure. You’ve got the beta blocker, ACEi/ARB, diuretic triad down pat. You know the mechanisms, the literature, and the monitoring. But what happens when those just aren’t enough? Time to turn to mechanics! But don’t worry, there’s plenty of pharmacotherapy to go around…

Heart Failure Part 3: Pharmacotherapy

Ok, so now onto pharmacotherapy - updated for the 2022 Guidelines!

Last time we talked about signs and symptoms and discussed the Frank-Starling curve. We are going to talk about the agents used in HF and how they affect this curve.

Clinical, Residency, PracticeBrandon DysonNovember 12, 2016heart failure, systolic heart failure, diastolic heart failure, HFpEF, HFrEF, HF, CHF, Clinical Pearls, congestive heart failure, cardiovascular, digoxin